White Paper

What Clinical Teams Should Know About The Benefits Of Auto-Injectors

Source: Thermo Fisher Scientific
What Clinical Teams Should Know About The Benefits Of Auto-Injectors

For a host of reasons, auto-injectors are becoming biopharma companies’ delivery method of choice for commercial use and late-stage clinical trials. Auto-injectors ensure that the prescribed dose of medication is delivered fully and completely,making it easier to track compliance in clinical trials. Multi-dose auto-injectors such as pens take the guesswork out of dosing by enabling patients to dial up the right dose every time. An added advantage for manufacturers is the combination of drug and delivery device can be branded and patent-protected. To learn more about the benefits of auto-injectors and information on Thermo Fisher Scientific’s auto-injector offerings, download the white paper.